[HTML][HTML] Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma

FH Kong, QF Ye, XY Miao, X Liu, SQ Huang, L Xiong… - Theranostics, 2021 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most common type of liver cancer and one of the
leading causes of cancer-related death worldwide. Advanced HCC displays strong …

[HTML][HTML] Targeted regulation of autophagy using nanoparticles: New insight into cancer therapy

MDA Paskeh, M Entezari, C Clark, A Zabolian… - … et Biophysica Acta (BBA …, 2022 - Elsevier
Normal cells depend on autophagy to maintain cellular homeostasis by recycling damaged
organelles and misfolded proteins and degrading toxic agents. Similar to apoptosis …

Nanostructured lipid carrier-based codelivery of raloxifene and naringin: formulation, optimization, in vitro, ex vivo, in vivo assessment, and acute toxicity studies

A Alhalmi, S Amin, Z Khan, S Beg, O Al Kamaly… - Pharmaceutics, 2022 - mdpi.com
This work aimed to develop dual drug-loaded nanostructured lipid carriers of raloxifene and
naringin (RLX/NRG NLCs) for breast cancer. RLX/NRG NLCs were prepared using …

Investigation on graphdiyne nanosheet in adsorption of sorafenib and regorafenib drugs: a DFT approach

U Srimathi, V Nagarajan, R Chandiramouli - Journal of Molecular Liquids, 2019 - Elsevier
We investigated the electronic characteristics of graphdiyne nanosheet (Gdn-NS) using first-
principles calculation. The Gdn-NS possesses the energy gap value of 0.52 eV. Also, the …

Therapeutic strategies for miRNA delivery to reduce hepatocellular carcinoma

B Roy, S Ghose, S Biswas - Seminars in Cell & Developmental Biology, 2022 - Elsevier
Malignancies of hepatocellular carcinoma (HCC) are rapidly spreading and commonly fatal.
Like most cancers, the gene expression patterns in HCC vary significantly from patient to …

Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma

Z Li, G Yang, L Han, R Wang, C Gong… - Journal of …, 2021 - Springer
In addition to early detection, early diagnosis, and early surgery, it is of great significance to
use new strategies for the treatment of hepatocellular carcinoma (HCC). Studies showed …

Tailoring Cu substituted hydroxyapatite/functionalized multiwalled carbon nanotube composite coating on 316L SS implant for enhanced corrosion resistance …

D Sivaraj, K Vijayalakshmi, A Ganeshkumar… - International Journal of …, 2020 - Elsevier
The aim of the present work is to study the potential change in the antibacterial properties of
Cu-hydroxyapatite/functionalized multiwall carbon nanotube (HA/f-MWCNT) composite …

Magnetic implants in vivo guiding sorafenib liver delivery by superparamagnetic solid lipid nanoparticles

RM Iacobazzi, F Vischio, I Arduino, F Canepa… - Journal of Colloid and …, 2022 - Elsevier
Abstract Hypothesis Solid lipid nanoparticles (SLNs), co-encapsulating superparamagnetic
iron oxide nanoparticles and sorafenib, have been exploited for magnetic-guided drug …

Recent advances in nanotechnology-based targeted therapeutics for breast cancer management

A Alhalmi, S Beg, WH Almalki… - Current Drug …, 2022 - ingentaconnect.com
Despite the great efforts that have been achieved in breast cancer treatment, it remains a
significant cause of death in women and is a serious health problem. Treatment with …

Recent advances in bionanomaterials for liver cancer diagnosis and treatment

MMH Chowdhury, CJJ Salazar, M Nurunnabi - Biomaterials science, 2021 - pubs.rsc.org
According to the World Health Organization, liver cancer is the fourth leading cause of
cancer associated with death worldwide. It demands effective treatment and diagnostic …